Last year, Alpha Teknova Inc generated 31.04M USD for its biggest-performing segment, Lab Essentials. The United States made the largest contribution, accounting for 38.25M USD last year. For the latest quarter, Alpha Teknova Inc reported the revenue of 9.18M USD for the period ending 2026-06-30, which came from the top-performing segment, Lab Essentials. United States contributed the highest revenue, at 11.66M USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Lab Essentials

Clinical Solutions

Other

Sample Transport

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Lab Essentials

31.04M(76.61%)

28.88M(76.52%)

28.80M(78.51%)

31.77M(76.71%)

27.18M(73.68%)

21.24M(67.87%)

18.11M(87.13%)

Clinical Solutions

7.65M(18.88%)

7.10M(18.80%)

6.74M(18.37%)

8.45M(20.39%)

6.79M(18.41%)

4.81M(15.36%)

1.36M(6.54%)

Other

1.83M(4.51%)

1.76M(4.68%)

1.15M(3.12%)

1.20M(2.89%)

1.39M(3.76%)

953.00K(3.05%)

1.31M(6.33%)

Sample Transport

--(--)

6.00K(0.01%)

1.53M(4.15%)

4.30M(13.73%)

--(--)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

United States

International

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

United States

38.25M(94.40%)

35.92M(95.16%)

35.00M(95.41%)

40.10M(96.82%)

35.81M(97.06%)

30.14M(96.30%)

19.81M(95.35%)

International

2.27M(5.60%)

1.83M(4.84%)

1.68M(4.59%)

1.32M(3.18%)

1.08M(2.94%)

1.16M(3.70%)

966.00K(4.65%)